Malaysia’s Medtech Sector Poised for High-Value Growth
2 October 2024, Pulau Pinang – The Malaysian Investment Development Authority (MIDA) and the Association of Malaysian Medical Industries (AMMI) today unveiled the AMMI’s Medical Device Industry Status and Outlook 2024/2025 Report: Malaysia, A Medtech Success Story at the Malaysia Medtech Industry Summit 2024 in Penang. This report underscores Malaysia’s position as the leading medtech hub in Southeast Asia, boasting the highest concentration of multinational medtech companies in the region.
Datuk Sikh Shamsul Ibrahim Sikh Abdul Majid, Chief Executive Officer of the Malaysian Investment Development Authority (MIDA), highlighted, “Malaysia’s medtech industry has witnessed impressive growth, and this report affirms our position as a key player in the global medtech landscape. As we look to the future, it’s clear that our professionals are not only masters of their technical craft, but also driven by a commitment to quality and compliance with global standards. This potent combination of talent and government support, as seen in initiatives such as the prioritisation of the medical device sector in the Twelfth Malaysia Plan and the New Industrial Master Plan (NIMP) 2030, has propelled Malaysia to the forefront of medtech innovation. MIDA is dedicated to supporting the sector’s continued expansion through strategic partnerships and proactive measures, and we’re excited to see what the future holds for this dynamic industry.”
AMMI Chairman, Mr. Andy Lee, expressed “Malaysia boasts the largest medical device market in Southeast Asia, with its market size reaching RM10.6 billion in 2023, and ranked among the top ten markets in Asia. Malaysia’s vibrant medical device ecosystem has been instrumental in attracting numerous investments to the country. It extends far beyond traditional manufacturing, offering robust capabilities in sterilisation, biocompatibility testing, packaging and conformity assessment. Malaysia hosts the largest sterilisation capacity in Southeast Asia, providing the most comprehensive range of sterilisation technologies in the region. These include Ethylene Oxide (EtO), Gamma, and Electron beam (E-beam) sterilisation. Furthermore, Malaysia stands as the first country in Southeast Asia to establish an X-ray sterilisation facility. Driven by its sophisticated infrastructure, adherence to international standards, and strong government support, Malaysia is well-positioned to remain competitive on the global stage.”
Demonstrating their confidence in Malaysia’s viability as a MedTech hub, AMMI members have steadily increased their investments. AMMI survey respondents plan to invest a collective amount of RM2.7 billion in expansion, RM927 million in new products and RM162 million in new research and development (R&D)/centre of excellence (COE) and Industry 4.0.
The report also highlights the significant contribution of AMMI to the local economy. Collectively, they sourced RM4.1 billion of raw materials and RM2.5 billion of services from local suppliers and small and medium-sized enterprises (SMEs). Additionally, contracts worth RM1.4 billion were outsourced to local suppliers, with 95% directed toward finished products.
Reflecting Malaysia’s long-term growth, MIDA will continue to collaborate with reputable associations like AMMI to ensure the nation remains attractive to investors. MIDA is committed to rolling out game-changing measures and attracting high-quality investments that generate high-income jobs, increase export value and strengthen Malaysia’s domestic supply chain ecosystem.
– THE END –
About MIDA
MIDA is the government’s principal investment promotion and development agency under the Ministry of Investment, Trade and Industry (MITI) to oversee and drive investments into the manufacturing and services sectors in Malaysia. Headquartered in Kuala Lumpur Sentral, MIDA has 12 regional and 21 overseas offices. MIDA continues to be the strategic partner to businesses in seizing the opportunities arising from the technology revolution of this era. For more information, please visit www.mida.gov.my and follow us on X, Instagram, Facebook, LinkedIn, TikTok and YouTube channel.
About Association of Malaysian Medical Industries (AMMI)
Persatuan Industri Perubatan Malaysia
马来西亚医疗器械行业协会
Since its establishment in 1989, the Association of Malaysian Medical Industries (AMMI) has been recognised as the voice of Malaysia’s medical device industry. AMMI’s vision is to make Malaysia the preferred global manufacturing and services location for medical technology. AMMI is represented by 91 members of reputable multi-national and local companies involved in developing and manufacturing medical device products, equipment, and services in Malaysia for the healthcare industry. Collectively, AMMI’s members account for more than half of the medical device export contributions, creating over 54,000 jobs.
Sejak penubuhan pada tahun 1989, Persatuan Industri Perubatan Malaysia (AMMI) telah diiktiraf sebagai suara industri peranti perubatan Malaysia. Visi persatuan adalah membina Malaysia sebagai salah satu pusat pembuatan dan perkhidmatan sedunia bagi industri teknologi perubatan.
AMMI mewakili 91 ahli syarikat bertaraf dunia termasuk multi-nasional dan syarikat tempatan dalam aktiviti pembangunan dan pembuatan peranti perubatan di Malaysia untuk dibekalkan kepada industry kesihatan sedunia. Eksport keseluruhan ahli AMMI mewakili lebih 50% eksport peranti perubatan di Malaysia dan menggaji lebih daripada 54,000 pekerja.
马来西亚医疗器械行业协会创会于1989年，是马来西亚医疗器械行业业者的代表。协会的目标是促进马来西亚成为全球医疗科技的制造与服务基地。
马来西亚医疗器械行业协会有91名会员公司，代表国际和本地的医疗器械厂商。会员公司的医疗器械总出口量超过马来西亚医疗器械一半的总出口量。马来西亚医疗器械行业协会的会员公司也为业界提供了超过五万四千个工作机会。
For more information, please contact:
MIDA:
Ms. Azlina Hamdan
Director, Life Sciences and Medical Technology Division, MIDA
Tel: +603-2267 3791
Email: [email protected]
AMMI:
Mr. CS Ching 庄骏雄
Executive Director
Tel: +6012 – 4766 558
Email : [email protected]
